Real World Evidence on Second-Line Palliative Chemotherapy in Advanced Pancreatic Cancer

Background: The outcome and tolerability of palliative second line chemotherapy for advanced pancreatic cancer (APC) in real life patients are largely unknown. Prognostic parameters for risk stratification and treatment guidance are lacking. Materials and Methods: A population based multicenter retr...

Descripción completa

Detalles Bibliográficos
Autores principales: Gränsmark, Emma, Bågenholm Bylin, Nellie, Blomstrand, Hakon, Fredrikson, Mats, Åvall-Lundqvist, Elisabeth, Elander, Nils O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397908/
https://www.ncbi.nlm.nih.gov/pubmed/32850339
http://dx.doi.org/10.3389/fonc.2020.01176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397908/
https://www.ncbi.nlm.nih.gov/pubmed/32850339
http://dx.doi.org/10.3389/fonc.2020.01176

Ejemplares similares